Apex Biotechnology Corp. (TPE:1733)
Taiwan · Delayed Price · Currency is TWD 31.80
-0.20 (-0.63%)
Jul 30, 2026, 10:49 AM CST
Apex Biotechnology Market Cap
Apex Biotechnology has a market cap or net worth of 3.2 billion as of July 29, 2026. Its market cap has increased by 11.50% in one year.
Market Cap
3.20B
Enterprise Value
2.64B
Revenue
1.91B
Ranking
n/a
PE Ratio
17.67
Stock Price
31.80
ChartMarket Cap Chart
Since September 7, 2001, Apex Biotechnology's market cap has increased from 1.43B to 3.20B, an increase of 124.45%. That is a compound annual growth rate of 3.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 3.20B | 5.09% |
| Dec 31, 2025 | 3.04B | 1.16% |
| Dec 31, 2024 | 3.01B | -25.31% |
| Dec 29, 2023 | 4.03B | 57.73% |
| Dec 30, 2022 | 2.55B | -1.73% |
| Dec 30, 2021 | 2.60B | 10.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senhwa Biosciences | 3.63B |
| OBI Pharma | 3.63B |
| Formosa Pharmaceuticals | 3.59B |
| Sagittarius Life Science | 3.38B |
| Great Novel Therapeutics Biotech & Medicals | 3.23B |
| SYN-TECH Chem. & Pharm. | 3.22B |
| Shine-On BioMedical | 3.14B |
| 3D Global Biotech | 3.07B |